Tag Directory / GOVERNMENTPOLICY     showing 1–4 of 4   RSS


for: Saturday, August 01, 2026



What We Know About Dr. Fauci Pleading the Fifth in Senate Hearing on Covid Origins

Sheryl Gay Stolberg and Benjamin Mueller / nytimes - In a three-hour Senate hearing this week, Dr. Fauci invoked his constitutional right to stay silent, leaving people confused about many of the issues raised.

AI Summary: A Senate hearing probing COVID-19’s origins put Dr. Anthony Fauci in the hot seat, with fierce questioning from senators including Rand Paul. At one point Fauci asserted his right against self-incrimination, sparking contentious exchanges, media analysis of his private notes and renewed debate about institutional decisions early in the pandemic.


Plea of Fifth and Contempt Proceedings in Senate Probe

26 days / abcnews


Private Notes, Cellphone Records and Political Fallout


Science, Media and Trust: Retractions and Expert Voices

23 days / oncodaily




Judge rejects states’ bid to pause Medicaid work requirements

Emily Olsen / healthcaredive - A federal judge this week said he wasn’t convinced that regulation detailing work requirements would cause irreparable harm to states. Still, the court will continue to hear the case.

AI Summary: A federal judge rejected a multi‑state request to pause implementation of Medicaid work requirement policies, finding insufficient grounds for an emergency stay. The ruling allows CMS guidance to remain in effect while legal challenges continue, leaving states and beneficiaries to navigate near‑term program changes amid ongoing litigation.


AI and administrative responses to enrollment churn

22 days / medicalxpress


Court rulings and Democratic opposition to the rule


Homeless people excluded from Medicaid exemptions

24 days / medicalxpress


State rollouts, insurer readiness and early coverage losses




HHS to stop funding ‘dangerous’ life sciences research

Paige Twenter / beckershospitalreview - The federal government will stop funding what it determines to be “dangerous” gain-of-function research conducted in the U.S. and abroad after implementing a new policy. The “Policy for Stopping High-Risk Life Sciences Research” lands during broader uphea…

AI Summary: The federal government announced a new policy curbing federal funding for defined categories of high‑risk life‑sciences research, citing biosafety and biosecurity concerns. The move pauses support for experiments judged to pose elevated pandemic or containment risks, sparking debate about how to balance oversight, scientific progress and public safety without stifling useful innovation.

23 days / oncodaily

24 days / bbc

4 wks / oncodaily

4 wks / oncodaily




CMS locks in 2.3% inpatient hospital base pay increase, nudges back CJR-X Model start date

fiercehealthcare - The Inpatient Prospective Payment System (IPPS) final rule's base pay increase is slightly below what was proposed earlier this year, though the agency said it now expects the rule's changes to bring hospital payments hundreds of millions of dollars highe…

AI Summary: CMS finalized a 2.3% increase to the inpatient hospital base rate and pushed back the start date of the mandatory CJR‑X (comprehensive joint replacement) model, giving providers extra runway to adjust. The move eases short‑term reimbursement pressure and shifts timing for hospitals’ budgeting, reporting, and operational changes tied to the joint‑replacement mandate.




Back to Top


GOVERNMENTPOLICY Heatmap


90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.


StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try CDC, Diagnostics, Venture Capital, Weight Loss and look for the RSS link.


NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.